U.S. Markets close in 2 hrs 6 mins
  • S&P 500

    3,672.77
    +51.14 (+1.41%)
     
  • Dow 30

    29,909.59
    +270.95 (+0.91%)
     
  • Nasdaq

    12,393.31
    +194.57 (+1.59%)
     
  • Russell 2000

    1,836.35
    +16.53 (+0.91%)
     
  • Crude Oil

    44.53
    -0.81 (-1.79%)
     
  • Gold

    1,819.60
    +38.70 (+2.17%)
     
  • Silver

    24.11
    +1.52 (+6.74%)
     
  • EUR/USD

    1.2051
    +0.0116 (+0.9761%)
     
  • 10-Yr Bond

    0.9190
    +0.0750 (+8.89%)
     
  • Vix

    20.39
    -0.18 (-0.88%)
     
  • GBP/USD

    1.3426
    +0.0094 (+0.7062%)
     
  • USD/JPY

    104.3600
    +0.0360 (+0.0345%)
     
  • BTC-USD

    18,794.30
    -605.47 (-3.12%)
     
  • CMC Crypto 200

    369.08
    -10.78 (-2.84%)
     
  • FTSE 100

    6,384.73
    +118.54 (+1.89%)
     
  • Nikkei 225

    26,787.54
    +353.92 (+1.34%)
     

Puma Biotech: 3Q Earnings Snapshot

·1 min read

LOS ANGELES (AP) _ Puma Biotechnology Inc. (PBYI) on Thursday reported a loss of $31.5 million in its third quarter.

The Los Angeles-based company said it had a loss of 79 cents per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 33 cents per share.

The biopharmaceutical company posted revenue of $50.8 million in the period, also missing Street forecasts. Three analysts surveyed by Zacks expected $53 million.

Puma Biotech shares have decreased 3% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $8.47, an increase of 17% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PBYI at https://www.zacks.com/ap/PBYI